252 related articles for article (PubMed ID: 8196571)
1. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
[TBL] [Abstract][Full Text] [Related]
3. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
Schiel X; Link H; Maschmeyer G; Glass B; Cornely OA; Buchheidt D; Wilhelm M; Silling G; Helmerking M; Hiddemann W; Ostermann H; Hentrich M
Infection; 2006 Jun; 34(3):118-26. PubMed ID: 16804654
[TBL] [Abstract][Full Text] [Related]
5. Interventional antimicrobial strategy in febrile neutropenic patients. Results of a multicenter study in 1,260 patients with hematological malignancies. The Interventional Antimicrobial Strategy Study Group, Paul Ehrlich Society for Chemotherapy.
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Adam D
Onkologie; 1990 Feb; 13(1):38-42. PubMed ID: 2186323
[TBL] [Abstract][Full Text] [Related]
6. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
7. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
Tromp YH; Daenen SM; Sluiter WJ; Vellenga E
Eur J Cancer; 2009 Mar; 45(4):596-600. PubMed ID: 19095436
[TBL] [Abstract][Full Text] [Related]
10. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.
Link H; Maschmeyer G; Meyer P; Hiddemann W; Stille W; Helmerking M; Adam D
Ann Hematol; 1994 Nov; 69(5):231-43. PubMed ID: 7948312
[TBL] [Abstract][Full Text] [Related]
11. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
12. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.
Böhme A; Shah PM; Stille W; Hoelzer D
Eur J Med Res; 1998 Jul; 3(7):324-30. PubMed ID: 9682028
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
18. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
Slobbe L; Waal Lv; Jongman LR; Lugtenburg PJ; Rijnders BJ
Eur J Cancer; 2009 Nov; 45(16):2810-7. PubMed ID: 19647995
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
Helbig W; Tauchnitz R
Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
